PE20040928A1 - Derivados de tetrahidroquinolinas como moduladores del receptor fsh - Google Patents
Derivados de tetrahidroquinolinas como moduladores del receptor fshInfo
- Publication number
- PE20040928A1 PE20040928A1 PE2004000023A PE2004000023A PE20040928A1 PE 20040928 A1 PE20040928 A1 PE 20040928A1 PE 2004000023 A PE2004000023 A PE 2004000023A PE 2004000023 A PE2004000023 A PE 2004000023A PE 20040928 A1 PE20040928 A1 PE 20040928A1
- Authority
- PE
- Peru
- Prior art keywords
- alcoxy
- dimetoxy
- trimethyl
- phenyl
- fsh receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Quinoline Compounds (AREA)
Abstract
SE REFIERE DERIVADOS DE TETRAHIDROQUINOLINA DE FORMULA I, DONDE R1 Y R2 SON H O Me; R3 ES H, HIDROXI, ALCOXI(C1-C4), (DI)ALQUILAMINO(C1-C4)-ALCOXI(C2-C4) O HETEROCICLOALQUIL(C2-C6)-ALCOXI(C2-C4); R4 Y R5 SON H, OH, ALCOXI(C1-C4) O R7; CON LA CONDICION DE QUE SI R4 ES H, R5 NO ES H, OH O ALCOXI(C1-C4) Y DE QUE SI R5 ES H, R4 NO ES H, OH o ALCOXI(C1-C4); R6 ES HETEROARIL(C2-C5), ARIL(C6), CICLOALQUILO(C3-C8), HETEROCICLOALQUIL(C2-C6) O ALQUIL(C1-C6), R7 ES AMINO, (DI)ALQUILAMINO(C1-C4), ARILCARBONILAMINO(C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-[1-ACETIL-5,7-DIMETOXI-4-(4-METOXI-FENIL)-2,2,4-TRIMETIL-1,2,3,4-TETRAHIDRO-QUINOLINA-6-IL]-3-CLORO-2,6-DIMETOXI-BENZAMIDA, 4,5-DIMETIL-FURAN-2-ACIDO CARBOXILICO [1-ACETIL-5,7-DIMETOXI-4-(4-METOXI-FENIL)-2,2,4-TRIMETIL-1,2,3,4-TETRAHIDRO-QUINOLINA-6-IL]-AMIDA, 5-BROMO-TIOFENO-2-ACIDO ACRBOXILICO [1-ACETIL5,7-DIMETOXI-4-(4-METOXI-FENIL)-2,2,4-TRIMETIL-1,2,3,4-TETRAHIDRO-QUINOLINA-6-IL]-AMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE LOS CONTIENE. ESTOS COMPUESTOS SON MODULARES DEL RECEPTOR DE FSH YA QUE PUEDEN UTILIZARSE COMO AGONISTAS(PARCIALES) O ANTAGONISTAS(PARCIALES) DEL RECEPTOR FSH, Y PUEDEN UTILIZARSE PARA TRATAR LA INFERTILIDAD, PARA LA ANTICONCEPCION Y PARA EL TRATAMIENTO DE DESORDENES HORMONO-DEPENDIENTES COMO CANCER DE MAMAS, DE PROSTATA Y ENDOMETRIOSIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02102866 | 2002-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20040928A1 true PE20040928A1 (es) | 2004-12-25 |
Family
ID=39311811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2004000023A PE20040928A1 (es) | 2002-12-20 | 2004-01-05 | Derivados de tetrahidroquinolinas como moduladores del receptor fsh |
Country Status (18)
Country | Link |
---|---|
US (1) | US7858794B2 (es) |
EP (1) | EP1578726B1 (es) |
JP (1) | JP4545001B2 (es) |
AR (1) | AR042630A1 (es) |
AT (1) | ATE423771T1 (es) |
AU (1) | AU2003298363B2 (es) |
BR (1) | BR0317518A (es) |
CA (1) | CA2508952C (es) |
CL (1) | CL2003002685A1 (es) |
ES (1) | ES2321830T3 (es) |
NZ (1) | NZ540578A (es) |
PE (1) | PE20040928A1 (es) |
PL (1) | PL377318A1 (es) |
RS (1) | RS51293B (es) |
RU (1) | RU2328488C2 (es) |
TW (1) | TWI306855B (es) |
UA (1) | UA81442C2 (es) |
WO (1) | WO2004056780A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8058441B2 (en) * | 2001-07-02 | 2011-11-15 | N.V. Organon | Tetrahydroquinoline derivatives |
TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
US7691848B2 (en) | 2005-03-02 | 2010-04-06 | Wyeth | Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists |
WO2006124581A2 (en) | 2005-05-12 | 2006-11-23 | Wyeth | Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists |
JP2008543765A (ja) | 2005-06-09 | 2008-12-04 | ワイス | 卵胞刺激ホルモンレセプターアンタゴニストとしてのピロロベンゾジアゼピンピリジンカルボキサミドおよび誘導体 |
AU2006319916A1 (en) | 2005-11-30 | 2007-06-07 | Astellas Pharma Inc. | 2-aminobenzamide derivative |
WO2008071455A1 (en) * | 2006-12-15 | 2008-06-19 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
EP1956016A1 (en) * | 2006-12-15 | 2008-08-13 | Bayer Schering Pharma Aktiengesellschaft | Bicyclic acyltryptophanols |
GB0705656D0 (en) * | 2007-03-23 | 2007-05-02 | Addex Pharmaceuticals Sa | Novel compounds E1 |
TW200918058A (en) * | 2007-08-31 | 2009-05-01 | Organon Nv | TSH receptor antagonizing tetrahydroquinoline compounds |
US8071587B2 (en) | 2009-05-27 | 2011-12-06 | N. V. Organon | (Dihydro)imidazoiso[5,1-A]quinolines |
US8431564B2 (en) | 2009-07-29 | 2013-04-30 | Merck Sharp & Dohme B.V. | Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
TW201116531A (en) * | 2009-07-29 | 2011-05-16 | Organon Nv | Ring-annulated dihydropyrrolo[2,1-a]isoquinolines |
WO2017192847A1 (en) * | 2016-05-04 | 2017-11-09 | University Of Cincinnati | Female fertility therapies |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2686182A (en) * | 1950-12-07 | 1954-08-10 | Basf Ag | O-hydroxy-dihydro-quinoline carboxylic acids |
DE19975054I2 (de) | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
DE69533180T2 (de) | 1994-12-22 | 2005-07-14 | Ligand Pharmaceuticals, Inc., San Diego | Steroidrezeptor-Modulator Verbindungen und Methoden |
CA2339018A1 (en) * | 1998-08-07 | 2000-02-17 | Applied Research Systems Ars Holding N.V. | Fsh mimetics for the treatment of infertility |
US6200963B1 (en) * | 1999-03-31 | 2001-03-13 | American Home Products Corporation | Aryl sulfonic acids as FSH antagonists |
US8058441B2 (en) * | 2001-07-02 | 2011-11-15 | N.V. Organon | Tetrahydroquinoline derivatives |
TWI322012B (en) * | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
TW592127U (en) * | 2003-05-19 | 2004-06-11 | Tatung Co | Network-type physiology monitoring device |
-
2003
- 2003-12-15 TW TW092135447A patent/TWI306855B/zh not_active IP Right Cessation
- 2003-12-16 RS YUP-2005/0457A patent/RS51293B/sr unknown
- 2003-12-16 BR BR0317518-9A patent/BR0317518A/pt active Search and Examination
- 2003-12-16 US US10/540,336 patent/US7858794B2/en not_active Expired - Lifetime
- 2003-12-16 RU RU2005122946/04A patent/RU2328488C2/ru not_active IP Right Cessation
- 2003-12-16 UA UAA200505288A patent/UA81442C2/xx unknown
- 2003-12-16 CA CA2508952A patent/CA2508952C/en not_active Expired - Lifetime
- 2003-12-16 NZ NZ540578A patent/NZ540578A/en not_active IP Right Cessation
- 2003-12-16 WO PCT/EP2003/051025 patent/WO2004056780A2/en active Application Filing
- 2003-12-16 ES ES03796105T patent/ES2321830T3/es not_active Expired - Lifetime
- 2003-12-16 PL PL377318A patent/PL377318A1/pl not_active Application Discontinuation
- 2003-12-16 AT AT03796105T patent/ATE423771T1/de not_active IP Right Cessation
- 2003-12-16 AU AU2003298363A patent/AU2003298363B2/en not_active Ceased
- 2003-12-16 JP JP2004561499A patent/JP4545001B2/ja not_active Expired - Fee Related
- 2003-12-16 EP EP03796105A patent/EP1578726B1/en not_active Expired - Lifetime
- 2003-12-18 CL CL200302685A patent/CL2003002685A1/es unknown
- 2003-12-19 AR ARP030104729A patent/AR042630A1/es unknown
-
2004
- 2004-01-05 PE PE2004000023A patent/PE20040928A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RS20050457A (en) | 2007-08-03 |
JP2006512347A (ja) | 2006-04-13 |
EP1578726A2 (en) | 2005-09-28 |
AU2003298363B2 (en) | 2009-09-24 |
AR042630A1 (es) | 2005-06-29 |
RU2005122946A (ru) | 2005-12-20 |
RU2328488C2 (ru) | 2008-07-10 |
US20060142334A1 (en) | 2006-06-29 |
JP4545001B2 (ja) | 2010-09-15 |
PL377318A1 (pl) | 2006-01-23 |
CL2003002685A1 (es) | 2005-04-08 |
AU2003298363A1 (en) | 2004-07-14 |
EP1578726B1 (en) | 2009-02-25 |
US7858794B2 (en) | 2010-12-28 |
ES2321830T3 (es) | 2009-06-12 |
BR0317518A (pt) | 2005-11-16 |
TWI306855B (en) | 2009-03-01 |
RS51293B (sr) | 2010-12-31 |
CA2508952A1 (en) | 2004-07-08 |
ATE423771T1 (de) | 2009-03-15 |
CA2508952C (en) | 2011-09-13 |
UA81442C2 (en) | 2008-01-10 |
WO2004056780A3 (en) | 2004-08-05 |
WO2004056780A2 (en) | 2004-07-08 |
NZ540578A (en) | 2006-12-22 |
TW200418800A (en) | 2004-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20040928A1 (es) | Derivados de tetrahidroquinolinas como moduladores del receptor fsh | |
ATE496620T1 (de) | 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren | |
CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
AR055592A1 (es) | Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace) | |
CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
CY1108908T1 (el) | Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4 | |
BR9910029A (pt) | Hidróxi indóis, sua aplicação como inibidores da fosfodiesterase 4 e processo para sua preparação | |
ES2182535T3 (es) | Derivados de benzo(b)tiepina-1,-dioxido, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su utilizacion. | |
CO5680438A2 (es) | Uso de derivados de ciclotiocarbamato en tratamiento de condiciones relacionadas con hormonas | |
ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
BR0311541A (pt) | indol, azaindol e 4-aquenil piperidina amidas heterocìclicas relacionadas | |
PE20030062A1 (es) | Derivados aralquilsulfonil-3-(pirrol-2-ilmetiliden)-2-indolinona como inhibidores de quinasas | |
TW200738631A (en) | Indole sulfonamide modulators of progesterone receptors | |
PE20011030A1 (es) | Combinaciones farmaceuticas que comprenden tegaserod y omeprazol | |
BR0312069A (pt) | Compostos de benzimidazol e seu uso como agonistas/antagonistas de estrogênio | |
AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
NO20061981L (no) | Arylindenopyridiner og arylindenopyridiner og deres anvendelse som adenosin A2A reseptoragonist | |
AR036327A1 (es) | Compuestos derivados del cromano para uso terapeutico, composicion farmaceutica, uso de estos compuestos para la preparacion de medicamentos para tratar migrana, compuestos relacionados, y procesos para preparar esos compuestos relacionados | |
ATE364044T1 (de) | 5ht2c rezeptor agonisten zur behandlung von diabetes und fettleibigkeit | |
ES2038678T3 (es) | Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos. | |
DK1448562T3 (da) | Substituerede tetracycliske pyrroloquinolonderivater egnede som phosphodiesteraseinhibitorer | |
EA200400896A1 (ru) | Терапевтические акридоновые и акридиновые соединения | |
CO2022004391A2 (es) | Derivados de 5-oxa-2–azaespiro[3.4]octano como agonistas de m4 | |
AR068381A1 (es) | Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6 | |
DE602004008300D1 (de) | Thiazolinderivate als selektive androgenrezeptormodulatoren (sarms) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |